Government Performance and Results Act (GPRA)
For more information about GPRA, including results prior to 2017 please click the link below:
For more information about the 2022 measures, including measure logic please click the link below:
Historical Summary Reports
To view the historical reports, the following pages are available.
- GPRA Report Summary 2022
-
A continuing emphasis on community oral health promotion/disease prevention is essential in order to address the current high prevalence, reduce the severity of oral disease and improve the oral health of American Indian/Alaska Native (AI/AN) people.
The IHS dental health measures support Healthy People 2030 oral conditions objectives.
Access to dental services is a prerequisite for the control of oral disease in susceptible or high-risk populations.
Topical fluorides and dental sealants have been extensively researched and documented in the dental literature as safe and effective preventive interventions to reduce tooth decay.
ACCESS TO DENTAL SERVICES
22.3%2022 Final Result
28.8% National Target
DENTAL SEALANTS
9.0%
2022 Final Result13.7% National Target
TOPICAL FLUORIDE
20.9%
2022 Final Result26.8% National Target
Diabetes prevention and treatment efforts are important priorities to decrease the onset of diabetes and its complications.
Controlling blood pressure reduces the risk that diabetic patients will develop heart disease, stroke, and kidney failure.
Adequate control of blood sugar levels reduces the risk that patients will develop complications of diabetes, such as heart, blood vessel, eye, kidney, and nerve problems.
Nephropathy assessments help to identify patients who are at risk for kidney disease.
Retinopathy assessments help to identify diabetic patients who are at higher risk for developing blindness.
People with diabetes have an increased risk of heart disease and stroke. Medications called statins help reduce this risk.
CONTROLLED BLOOD PRESSURE <140/90
53.0%2022 Final Result
57.0% National Target
POOR GLYCEMIC CONTROL
14.6%
2022 Final Result15.6% National Target
NEPHROPATHY ASSESSED
41.0%
2022 Final Result43.7% National Target
RETINOPATHY EXAM
41.8%
2022 Final Result41.2% National Target
STATIN THERAPY
58.5%
2022 Final Result56.8% National Target
Routine immunizations represent a cost-effective public health approach to protect individuals from preventable infectious diseases.
IHS tracked four immunizations nationally in 2022.
Two measures targeted children: combined (4:3:1:3:3:1:4) childhood series for children 19 – 35 months and an annual influenza vaccination for children 6 months to 17 years.
Two adult vaccination measures are included: annual influenza vaccination for adults 18+ and an adult composite immunization.
CHILDHOOD IMMUNIZATIONS
36.1%2022 Final Result
47.8% National Target
INFLUENZA VACCINATION 6 MO-17 YRS
18.5%
2022 Final Result29.7% National Target
INFLUENZA VACCINATION 18+
20.0%
2022 Final Result28.0% National Target
ADULT COMPOSITE IMMUNIZATION
36.1%
2022 Final Result44.4% National Target
Prevention measures focus attention on early detection of disease (cancer screenings) and management of risk factors to prevent disease (tobacco cessation and HIV screening).
Prevention can focus on appropriate treatment of chronic conditions (cholesterol and blood pressure treatment) to avoid complications.
Prevention also focuses on healthy behaviors/lifestyles (childhood weight control and infant breastfeeding) that have been shown to prevent diseases.
(CERVICAL) PAP SCREENING
33.2%2022 Final Result
Baseline
COLORECTAL CANCER SCREENING
23.7%
2022 Final ResultBaseline
MAMMOGRAPHY SCREENING
29.2%
2022 Final Result39.7% National Target
TOBACCO CESSATION
25.0%
2022 Final Result29.8% National Target
HIV SCREENING EVER
38.0%
2022 Final Result38.0% National Target
CVD STATIN THERAPY
42.7%
2022 Final Result40.6% National Target
CONTROLLING HIGH BLOOD PRESSURE-MILLION HEARTS
45.5%
2022 Final Result40.9% National Target
CHILDHOOD WEIGHT CONTROL
23.0%
2022 Final Result22.6% National Target
BREASTFEEDING RATES
39.3%
2022 Final Result42.0% National Target
High rates of alcohol and substance abuse, mental health disorders, suicide, violence, and behavior-related chronic diseases in American Indian and Alaska Native communities are well documented.
Each of these serious behavioral health issues has a profound impact on the health of individuals, families, and communities.
Two measures relate to alcohol screening or identifying patients with risky or harmful alcohol use and provide them with a brief negotiated interview.
Two depression screening measures span ages 12 and older.
The intimate partner (domestic) violence (IPV/DV) measure identifies women 14 – 46 years who have been screened for IPV/DV.
UNIVERSAL ALCOHOL SCREENING
33.2%2022 Final Result
39.2% National Target
SCREENING, BRIEF INTERVENTION & REFERRAL TO TREATMENT
14.3%2022 Final Result
13.5% National Target
DEPRESSION SCREENING 12-17 YRS
32.1%2022 Final Result
33.9% National Target
DEPRESSION SCREENING 18+
37.0%2022 Final Result
42.9% National Target
INTIMATE PARTNER VIOLENCE/ DOMESTIC VIOLENCE SCREENING
28.3%2022 Final Result
36.3% National Target
GPRA/GPRAMA National and Area Results
- FY 2021 GPRA/GPRAMA National and Area Results [PDF - 4 MB]
- FY 2020 GPRA/GPRAMA National and Area Results [PDF - 4 MB]
- FY 2019 GPRA/GPRAMA National and Area Results [PDF - 228 KB]
- FY 2018 GPRA/GPRAMA National and Area Results [PDF - 2 MB]
- FY 2017 GPRA/GPRAMA National and Area Results [PDF - 2 MB]